ENTPD1 and malignant colon neoplasm: Consequently the prognostic effect of CD39 expression by Treg in colon cancer is difficult to envision, even though an enriched CD39+ Treg population likely shifts the balance to a proportionally higher level of adenosine receptor signaling.